Evidence map›Paper›PMID 33639904›Full record

ArticleBMC public health2021

Stopping, starting, and sustaining HIV antiretroviral therapy: a mixed-methods exploration among African American/Black and Latino long-term survivors of HIV in an urban context.

Marya Gwadz, Charles M Cleland, Robert Freeman, Leo Wilton, Linda M Collins, Robert L Hawkins, Amanda S Ritchie, Noelle R Leonard, Danielle F Jonas, Alexis Korman and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Marya GwadzCenter for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA. marya.gwadz@nyu.edu.ORCID 0000-0002-2386-9409
Charles M ClelandCenter for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA.
Robert FreemanIndependent Consultant, Brooklyn, NY, USA.
Leo WiltonDepartment of Human Development, State University of New York at Binghamton, Binghamton, NY, USA.
Linda M CollinsMethodology Center and Department of Human Development and Family Studies, Pennsylvania State University, State College, PA, USA.
Robert L HawkinsNew York University Silver School of Social Work, New York, NY, USA.
Amanda S RitchieNew York University Silver School of Social Work, New York, NY, USA.
Noelle R LeonardCenter for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA.
Danielle F JonasNew York University Silver School of Social Work, New York, NY, USA.
Alexis KormanNew York University School of Medicine, New York, NY, USA.
Sabrina CluesmanNew York University Silver School of Social Work, New York, NY, USA.
Ning HeNew York University Silver School of Social Work, New York, NY, USA.
Dawa SherpaNew York University Silver School of Social Work, New York, NY, USA.
New York University · USBinghamton University · USPennsylvania State University · US

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Using MOST to optimize an HIV care continuum intervention for vulnerable populationsR01DA040480 · NIDA · NEW YORK UNIVERSITY · PI COLLINS, LINDA M, GWADZ, MARYA · 2016 to 2020
$5.9M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA040480NIDA NIH HHS R01DA040480NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

backgroundAlthough periods of HIV antiretroviral therapy (ART) discontinuation have deleterious health effects, ART is not always sustained. Yet, little is known about factors that contribute to such ART non-persistence among long-term HIV survivors. The present study applied a convergent parallel mixed-methods design to explore the phenomena of stopping/starting and sustaining ART, focusing on low-socioeconomic status African American or Black and Latino persons living with HIV (PLWH) who face the greatest challenges.

methodsParticipants (N = 512) had poor engagement in HIV care and detectable HIV viral load. All received structured assessments and N = 48 were randomly selected for in-depth interviews. Quantitative analysis using negative binomial regression uncovered associations among multi-level factors and the number of times ART was stopped/started and the longest duration of sustained ART. Qualitative data were analyzed using a directed content analysis approach and results were integrated.

resultsParticipants were diagnosed 18.2 years ago on average (SD = 8.6), started ART a median five times (Q1 = 3, Q3 = 10), and the median longest duration of sustained ART was 18 months (Q1 = 6, Q3 = 36). Factors associated with higher rates of stops/starts were male sex, transgender identity, cannabis use at moderate-to-high-risk levels, and ART- and care-related stigma. Factors associated with lower rates of stops/starts were older age, more years since diagnosis, motivation for care, and lifetime injection drug use (IDU). Factors associated with longer durations of sustained ART were Latino/Hispanic ethnicity, motivation for ART and care, and recent IDU. Factors associated with a shorter duration were African American/Black race, alcohol use at moderate-to-high-risk levels, and social support. Qualitative results uncovered a convergence of intersecting risk factors for stopping/starting ART and challenges inherent in managing HIV over decades in the context of poverty. These included unstable housing, which contributed to social isolation, mental health distress, and substance use concerns, the latter prompting selling ("diverting") ART. Primarily complementary quantitative and qualitative findings described mechanisms by which risk/protective factors operated and ways PLWH successfully restart and/or sustain ART.

conclusionsThe field focuses substantially on ART adherence, but greater attention to reducing the frequency of ART non-persistence is needed, along with creating social/structural conditions favorable for sustained ART.

Indexed as

Black or African AmericanHIV InfectionsAgedAnti-Retroviral AgentsFemaleHispanic or LatinoHumansMaleSurvivorsAnti-Retroviral AgentsDisparitiesHIV antiretroviral therapyHIV survivorshipInitiationMixed methodsNon-persistencePovertyRace/ethnicityResilienceSubstance use

Identifiers

PMID33639904
PMCPMC7912958
OpenAlexW3133994050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.